- Published on
Diagnostic Tests-Tests: D-Dimer and Fibrin Split Products
Overview
D-dimer and fibrin split products (FSPs) are laboratory markers that reflect activation of the coagulation and fibrinolytic systems. D-dimer is generated when plasmin degrades cross-linked fibrin, whereas fibrin split products are formed when thrombin acts on fibrinogen, producing degradation fragments. Both markers become clinically significant when elevated, as they indicate abnormal or excessive clot formation and breakdown within the body.
Measurement Methods
D-dimer levels can be measured through two commonly used laboratory techniques:
Fibrin split products are measured through similar immunologic methods, but they are primarily ordered in the evaluation of disseminated intravascular coagulation (DIC).
What These Tests Detect
Elevated D-dimer and FSP levels indicate pathologic clot formation and subsequent fibrinolysis. When the coagulation cascade is activated, fibrin clots form and are later broken down, generating measurable fragments.
Importantly, these tests do not assess platelet function and provide no information about platelet aggregation or adhesion disorders.
Interpretation of Test Results
When to Order These Tests
D-dimer and fibrin split products should be ordered in the following scenarios:
Overview
D-dimer and fibrin split products (FSPs) are laboratory markers that reflect activation of the coagulation and fibrinolytic systems. D-dimer is generated when plasmin degrades cross-linked fibrin, whereas fibrin split products are formed when thrombin acts on fibrinogen, producing degradation fragments. Both markers become clinically significant when elevated, as they indicate abnormal or excessive clot formation and breakdown within the body.
Measurement Methods
D-dimer levels can be measured through two commonly used laboratory techniques:
- Latex agglutination assay:
A rapid test, useful for quick screening but less sensitive. - ELISA (enzyme-linked immunosorbent assay):
The most accurate and far more sensitive method, capable of detecting very low levels of D-dimer. Because of its high sensitivity, the ELISA is the preferred test when ruling out thrombotic conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).
Fibrin split products are measured through similar immunologic methods, but they are primarily ordered in the evaluation of disseminated intravascular coagulation (DIC).
What These Tests Detect
Elevated D-dimer and FSP levels indicate pathologic clot formation and subsequent fibrinolysis. When the coagulation cascade is activated, fibrin clots form and are later broken down, generating measurable fragments.
Importantly, these tests do not assess platelet function and provide no information about platelet aggregation or adhesion disorders.
Interpretation of Test Results
- Elevated levels suggest active clot formation and breakdown and are characteristic of conditions such as:
- Disseminated intravascular coagulation (DIC)
- Recent surgery or trauma
- Infection or sepsis
- Malignancy
- Venous thromboembolism (DVT or PE)
- A negative ELISA D-dimer is powerful for ruling out DVT or PE in patients with a low pretest probability.
- However, a positive D-dimer is not diagnostic of DVT or PE because many conditions can elevate it.
- In DIC, both D-dimer and fibrin split products are elevated, reflecting uncontrolled coagulation and fibrinolysis.
When to Order These Tests
D-dimer and fibrin split products should be ordered in the following scenarios:
- To evaluate suspected DIC, particularly when accompanied by thrombocytopenia, prolonged PT/aPTT, and clinical evidence of bleeding or thrombosis.
- To rule out pulmonary embolism or deep vein thrombosis, but only in patients with low pretest probability, where a negative ELISA D-dimer effectively excludes the diagnosis.
- As supportive evidence in conditions involving widespread clot formation and fibrinolysis.
0 Comments
